DE60136360D1 - Antigen aus streptococcus pyogenes - Google Patents

Antigen aus streptococcus pyogenes

Info

Publication number
DE60136360D1
DE60136360D1 DE60136360T DE60136360T DE60136360D1 DE 60136360 D1 DE60136360 D1 DE 60136360D1 DE 60136360 T DE60136360 T DE 60136360T DE 60136360 T DE60136360 T DE 60136360T DE 60136360 D1 DE60136360 D1 DE 60136360D1
Authority
DE
Germany
Prior art keywords
antigen
streptococcus pyogenes
streptococcus
prophylaxis
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60136360T
Other languages
English (en)
Inventor
Denis Martin
Josee Hamel
Bernard Brodeur
Stephane Rioux
Martine Boyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ID Biomedical Corp of Quebec
Original Assignee
ID Biomedical Corp of Quebec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ID Biomedical Corp of Quebec filed Critical ID Biomedical Corp of Quebec
Application granted granted Critical
Publication of DE60136360D1 publication Critical patent/DE60136360D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60136360T 2000-07-06 2001-07-06 Antigen aus streptococcus pyogenes Expired - Lifetime DE60136360D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21646500P 2000-07-06 2000-07-06
PCT/CA2001/001001 WO2002004495A2 (en) 2000-07-06 2001-07-06 Streptococcus pyogenes antigen

Publications (1)

Publication Number Publication Date
DE60136360D1 true DE60136360D1 (de) 2008-12-11

Family

ID=22807177

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60136360T Expired - Lifetime DE60136360D1 (de) 2000-07-06 2001-07-06 Antigen aus streptococcus pyogenes

Country Status (10)

Country Link
US (2) US7247308B2 (de)
EP (1) EP1297145B1 (de)
JP (1) JP4718099B2 (de)
AT (1) ATE412750T1 (de)
AU (1) AU7227001A (de)
BR (1) BR0112497A (de)
CA (1) CA2413576C (de)
DE (1) DE60136360D1 (de)
ES (1) ES2316458T3 (de)
WO (1) WO2002004495A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4718099B2 (ja) * 2000-07-06 2011-07-06 アイディー バイオメディカル コーポレイション ストレプトコッカス・パイオジェンス抗原
EP2277894A1 (de) 2000-10-27 2011-01-26 Novartis Vaccines and Diagnostics S.r.l. Nukleinsäure und Proteine von Gruppen A und B Streptokokken
DE60134494D1 (de) * 2000-12-21 2008-07-31 Id Biomedical Corp Antigene aus streptococcus pyogenes und zugehörige dna-fragmente
EP1597348A4 (de) * 2002-08-26 2010-03-31 Novartis Vaccines & Diagnostic Konservierte und spezifische streptokokkengenome
WO2005032582A2 (en) 2003-07-31 2005-04-14 Chiron Corporation Immunogenic compositions for streptococcus pyogenes
ES2432013T3 (es) * 2003-08-15 2013-11-29 Id Biomedical Corporation Of Quebec Composiciones farmacéuticas para usar en el tratamiento de la infección por Streptococcus Pyogenes
US8945589B2 (en) * 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
EP1784211A4 (de) 2004-07-29 2010-06-30 Novartis Vaccines & Diagnostic Immunogene zusammensetzungen für grampositive bakterien wie streptococcus agalactiae
EP1807446A2 (de) * 2004-10-08 2007-07-18 Novartis Vaccines and Diagnostics, Inc. Immunogene und therapeutische zusammensetzungen für pyogene streptokokken
GB2428006A (en) * 2005-07-07 2007-01-17 Jevgenis Morov AMI-3 vaccine comprising group A Streptococcus pyogenes bacteria
ATE522541T1 (de) * 2006-06-09 2011-09-15 Novartis Ag Bakterielle adhäsine konformere
AU2007348285A1 (en) * 2006-10-30 2008-09-12 Novartis Ag Immunogenic and therapeutic compositions for streptococcus pyogenes
AU2008299376B2 (en) 2007-09-12 2013-02-28 Glaxosmithkline Biologicals S.A. GAS57 mutant antigens and GAS57 antibodies
RU2498994C2 (ru) 2007-12-21 2013-11-20 Новартис Аг Мутантные формы стрептолизина о
CN107312075B (zh) 2011-06-17 2021-01-12 田纳西大学研究基金会 A群链球菌多价疫苗
WO2014124446A1 (en) 2013-02-11 2014-08-14 University Of Tennessee Research Foundation Group a streptococcal m-related proteins and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0916726A1 (de) * 1997-11-13 1999-05-19 Rijksuniversiteit te Groningen Befestigungs-Substanzen an Mikroorganismen
JP4718099B2 (ja) 2000-07-06 2011-07-06 アイディー バイオメディカル コーポレイション ストレプトコッカス・パイオジェンス抗原

Also Published As

Publication number Publication date
EP1297145A2 (de) 2003-04-02
JP4718099B2 (ja) 2011-07-06
ATE412750T1 (de) 2008-11-15
WO2002004495A2 (en) 2002-01-17
EP1297145B1 (de) 2008-10-29
US7811585B2 (en) 2010-10-12
US20030165528A1 (en) 2003-09-04
WO2002004495A3 (en) 2002-06-13
JP2004502446A (ja) 2004-01-29
CA2413576C (en) 2012-11-13
US7247308B2 (en) 2007-07-24
US20080038268A1 (en) 2008-02-14
BR0112497A (pt) 2003-11-25
AU7227001A (en) 2002-01-21
CA2413576A1 (en) 2002-01-17
ES2316458T3 (es) 2009-04-16

Similar Documents

Publication Publication Date Title
BE2021C506I2 (de)
ATE412750T1 (de) Antigen aus streptococcus pyogenes
ATE542829T1 (de) Impfstoff
ATE426412T1 (de) Adjuvante influenza-vakzine
WO2004030608A3 (en) Nanoemulsion vaccines
IL188667A0 (en) Host cell infected by a modified vaccinia virus ankara (mva)
DK1255826T3 (da) Automatisering af proteindesign for proteinbiblioteker
WO2006042027A8 (en) Immunogenic and therapeutic compositions for streptococcus pyogenes
ATE227134T1 (de) Chitosan-impfstoff-zusammensetzungen zur intranasalen verabreichung und anwendungen
MY125202A (en) Vaccine
DK1283887T3 (da) Kimære Arterivirus-lignende partikler
AP2002002685A0 (en) Use of flavivirus for the expression of protein epitpoes and development of new live attenuated vaccine virus to immune against flavivirus and other infectious agents
AP2003002734A0 (en) Purification of HBV antigens for use in vaccines.
DE60226175D1 (de) Mycobakterieller impfstoff
DK1395283T3 (da) Heterolog beskyttelse induceret ved immunisering med Invaplex-vaccine
IL156799A0 (en) Peptides having affinity for the gp120 viral protein and use thereof
ATE456659T1 (de) Streptococcus pyogenes polypeptide und entsprechende dna fragmente
SG147465A1 (en) Vaccine
DE60234772D1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente
WO2003059252A3 (en) Use of a novel cell surface protease from group b streptococcus
DK1275638T3 (da) Kombinationspræparat til behandling af immunologiske sygdomme
DK1301188T3 (da) Anthelminthika til forhindring af parasitinfektioner hos mennesker og dyr

Legal Events

Date Code Title Description
8364 No opposition during term of opposition